RESULTS	Accordingly , the target vessel revascularization and major adverse cardiac and cerebrovascular events rates at one year in the VBT group ( 20.4 % and 25.9 % , respectively ) were higher than in the control group ( 12.1 % and 17.2 % , respectively ) .\